Dobrin Vassilev
Latest contributions
Navigating complexity: TAVI in challenging anatomies
22 May 2025 – From EuroPCR 2025
Navigate the complexities of TAVI in challenging anatomies. This session reviews anatomical variations such as horizontal aorta, iliofemoral tortuosity, low coronary ostia, bicuspid valves, and annular eccentricity, alongside preprocedural imaging and risk stratification. It further evaluates device selection and procedural adaptations essential for successful TAVI in...
Metalfree PCI
21 May 2025 – From EuroPCR 2025
Explore metal-free PCI approaches emphasizing drug-coated balloon angioplasty and bioresorbable scaffold technologies. This session reviews angiographic outcomes in diffuse small vessel disease, bifurcation lesions, and acute myocardial infarction, alongside management strategies for restenosis post-DCB angioplasty, highlighting advancements in minimally invasive coronary interventions.
Bifurcation stenting techniques outcomes
21 May 2025 – From EuroPCR 2025
Examine the outcomes of various bifurcation stenting techniques with insights from multiple registries and trials. This session compares guidance methods and evaluates clinical results of double kissing culotte, nano-crush, POKI, and DK crush techniques in different lesion settings.
CTO PCI: from planning to execution
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the Cyprus Society of Cardiology / Cyprus Interventional Cardiology Working Group, Tunisian Group for Interventional Cardiology and Bulgarian Society of Interventional Cardiology, covers planning and execution of CTO PCI procedures. It includes case discussions on treatment dilemmas, overcoming frequently encountered...
Stenting techniques in bifurcation lesions
15 May 2024 – From EuroPCR 2024
Thanks to this EuroPCR 2024 session, explore temporal trends in left main bifurcation PCI, study geometric variations in coronary arteries at bifurcations, and decode Medina 0-0-1 bifurcations. Learn to compare mini-crush and TAP stenting techniques, analyze cardiovascular outcomes, and evaluate the POKI technique versus kissing balloon...
TAVI in heavily calcified aortic disease - How to choose the proper treatment strategy?
18 May 2023 – From EuroPCR 2023
Consult this session if you want to outline how the heart team should individualise treatment for patients with complex calcified aortic stenosis, to review steps for TAVI in complex calcified aortic stenosis, and to learn about device selection and implantation techniques in calcified anatomies.
Changes of STEMI in young patients
17 May 2023 – From EuroPCR 2023
This session will enable you to gain knowledge about "Changes in ST-segment elevation myocardial infarction (STEMI) in young patients" and explore the implications for diagnosis and treatment through a series of challenging real-life case presentations.
Bifurcations
17 May 2023 – From EuroPCR 2023
Seeking to revive your understanding of this session focusing on bifurcations? Examine these slides and review the main elements of the presentations.
EuroPCR 2021 Hotlines / Late-Breaking Trials in bifurcation lesions: EBC MAIN and more!
21 May 2021 – From EuroPCR 2021
Find out more about various studies & registries in bifurcation lesions:
- EBC MAIN - the European Bifurcation Club Left Main Coronary Bifurcation Study
- Clinical Outcomes after Physiology-Guided Treatment of Coronary Bifurcations
Distal left main stenosis: how to treat optimally with dedicated bifurcation stent BiOSS Lim C. Case-based session
22 May 2019 – From EuroPCR 2019
Consult this session to learn more about the multiple technological options with dedicated bifurcation stent for complex left main bifurcation lesions, and the applicability of this stent for the different clinical presentations.
Beyond the limit – Left main PCI in high-risk patients and complex anatomy
22 May 2019 – From EuroPCR 2019
Consult this session to learn about the treatment options for patients with complex anatomy not suitable for operative revascularisation, the strategies for lesion preparation in left main coronary artery in stable and ACS patient and for left main coronary artery stenting in high-risk patients.
